2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
8
Neoplasms
3
Esophageal Neoplasms
2
Stomach Neoplasms
1
Platelet Glycoprotein IV Deficiency
1
Pancreatic Intraductal Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Cyst
1
Neoplasm Metastasis
1
Leiomyoma
1
Jaundice, Obstructive
1
Gastrointestinal Stromal Tumors
1
Fatty Liver
1
Disease
1
Cysts
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Adrenal Gland Neoplasms
1
Adrenal Gland Diseases
1
Adenocarcinoma
1
Interventions
Oxaliplatin
46
Gemcitabine
45
Fluorouracil
40
Capecitabine
31
pembrolizumab
30
Leucovorin
29
Docetaxel
27
Cisplatin
25
Paclitaxel
23
Irinotecan
18
Carboplatin
18
Bevacizumab
18
130-nm albumin-bound paclitaxel
17
Radiotherapy
16
Pemetrexed
15
Albumin-Bound Paclitaxel
15
Nivolumab
13
Ramucirumab
11
Cyclophosphamide
11
Drug Therapy
9
Trastuzumab
8
Erlotinib Hydrochloride
8
zolbetuximab
7
Taxes
7
Radiosurgery
7
trastuzumab deruxtecan
6
cemiplimab
6
Blood Specimen Collection
6
regorafenib
5
durvalumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Endosonography
×
Clear all
NCT06867172
2025-03-10
SPACE
Carol Davila University of Medicine and Pharmacy
Recruiting
66 enrolled